Exact tumor type
Melanoma, squamous cell carcinoma, basal cell carcinoma, Merkel cell carcinoma or another diagnosis must be specified.
Oncology evaluation directory
Dermato-oncology
Skin Cancer Evaluation
A specialist-oriented review for selected skin cancers, including melanoma and complex non-melanoma tumors, organized around pathology, depth or risk features, nodal status, imaging and prior local or systemic treatment.
Medical disclaimer: This page is informational and coordination-focused. It does not diagnose, prescribe, promise treatment suitability or replace urgent local medical care.
Clinical file logic
What the specialist needs to understand before any treatment discussion.
Skin cancer is a broad term. A superficial basal cell carcinoma, high-risk squamous cell carcinoma and melanoma require very different clinical questions. The review therefore begins with the exact pathology and risk features.
The page is designed for cases where a deeper file review is needed: recurrence, nodal disease, metastatic disease, difficult location, previous treatment failure or need for a second opinion.
Pathology risk features
Breslow depth, ulceration, margins, perineural invasion, grade and other details are reviewed where applicable.
Nodal and metastatic status
Sentinel node, lymph node imaging and distant staging are documented.
Molecular context
BRAF and other markers are included when relevant for melanoma or advanced disease.
Prior treatment
Excision, lymph node surgery, radiation, immunotherapy, targeted therapy and recurrence timing are summarized.
Functional/anatomic issue
Tumors near face, scalp, hands, genitals or irradiated areas may need special routing.
Evaluation matrix
How the case is reviewed without reducing it to a diagnosis name.
Each item below affects how the file is interpreted, what the physician can answer and whether additional documents are needed before a responsible response.
Not all skin cancers are equal
The review avoids treating “skin cancer” as one disease category.
Local control questions
Margins, recurrence and reconstructive feasibility affect whether local treatment is a central issue.
Systemic review
Advanced melanoma or high-risk disease may require systemic therapy history and biomarker review.
Documentation quality
Clear photos help but do not replace pathology, imaging and operative reports.
Documents to prepare
A complete medical file prevents delay and unrealistic expectations.
Most delays happen when the diagnosis is described verbally but the file lacks dates, reports, imaging, pathology or the current specialist recommendation. The documents below are requested before the file is considered ready for review.
Cuba context
How Cuba-related options are framed responsibly.
The page does not present a hospital visit or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
Pathology drives routing
No image-based promise is made without confirmed tissue diagnosis and clinical context.
Photos are supportive
Photos are useful for orientation but not enough for treatment suitability.
International timing is individualized
Rapidly growing, bleeding or infected lesions may require local attention before travel.
When local care comes first
Do not wait for international review if urgent symptoms are present.
International coordination should never delay emergency care. If any of the following are present, the patient should be assessed locally first.
- Rapid bleeding, infection, severe pain or foul-smelling ulceration.
- New neurological symptoms or rapidly enlarging lymph nodes.
- Sudden decline during systemic therapy or severe immune-related side effects.
Coordination pathway
From records to written next steps.
- File intakeReports, imaging, summaries and current symptoms are uploaded through the application flow.
- Quality checkThe coordination team checks readability, dates, translation needs and missing items.
- Specialist routingThe case is prepared around a clear medical question and routed to the relevant review pathway.
- Written responseThe patient receives an organized next-step explanation before travel, payment or treatment logistics are considered.
Questions
Before starting the application.
Does this page mean I am suitable for a Cuba-based treatment?
No. It explains how the file is organized for review. Suitability, route, timing and safety can only be determined by physicians after reviewing the complete current record.
Can I send only a short summary?
A summary helps, but it is not enough for most oncology reviews. Pathology, imaging, treatment history, lab results and the latest oncology note are usually needed.
Will the coordinator choose my treatment?
No. Cuba Health Assist coordinates records, communication, translation support and logistics. Medical decisions remain with licensed physicians and the patient’s treating team.
What happens if my file is incomplete?
The team will request missing reports before presenting the case as ready. This protects the patient from receiving a weak or unrealistic response.
Can urgent symptoms be handled through this page?
No. Severe or rapidly worsening symptoms require local emergency or oncology care first. International coordination is not an emergency service.
Related evaluation pages
Other oncology files reviewed in the same clinical directory.
Start with the file
Submit documents before making a travel or treatment decision.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.